Temporary treatment during primary HIV infection does not affect virologic response to subsequent long-term treatment.

Temporary cART during primary HIV-infection (PHI) did not select for drug resistance mutations after treatment interruption and did not affect the subsequent virological response to long-term cART. Our data demonstrate that fear of drug resistance development is not a valid argument to refrain from...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marlous L Grijsen, Ferdinand W N M Wit, Suzanne Jurriaans, Frank P Kroon, Emile F Schippers, Peter Koopmans, Luuk Gras, Joep M A Lange, Jan M Prins, Primo-SHM Study Group
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/aa29d1b1c52a4b98a97ba1747b59e561
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!